Corteva wins judgment against Inari's invalidity counterclaims in US patent suit

Inari was denied judgments of noninfringement on most US patent claims brought by Corteva regarding corn and soybean crops. District Judge John F. Murphy allowed only five of Corteva's claims to be dismissed.

Corteva plans to spin off its advanced seed and genetics business, Vylor, by October 1, 2026. The company presented a corn innovation roadmap, highlighting proprietary biotechnology and gene editing technologies expected to generate over $2bn in incremental revenue by 2035, including licensing income. Vylor aims to transition to a technology licensor, creating recurring revenue streams from proprietary genetics and traits.

Corteva (CTVA) extended its debt exchange offer after 93.7% early participation. Over 86% of three series of senior notes were tendered by the deadline. The company aims to remove restrictive covenants ahead of its planned separation into two public companies by October 1, 2026. The offer's expiration date was extended to September 29, 2026.

Corteva (CTVA) extended its debt exchange deadline to September 29, 2026, after receiving strong early tender results for its EIDP senior notes. Over 86% of the 2030 and 2033 notes and 93.69% of the 2032 notes were tendered. The exchange supports Corteva's planned separation into two public companies, with amendments to remove restrictive covenants and change-of-control provisions.

UBS analyst Joshua Spector reduced Corteva's (CTVA) price target to $85 from $89, maintaining a Neutral rating. The analyst notes Corteva's favorable setup for upcoming investor events and a potential for upside surprises despite slower growth expectations in 2027.

California Attorney General Rob Bonta alleges in a federal filing that DuPont and three spin-offs used memorandums of understanding to shift most PFAS liabilities onto Chemours while limiting exposure for Corteva, New DuPont and Qnity. Bonta cites possible fraudulent transfer law violations. DuPont disputes; a prior New Jersey case settled for $2 billion.